AI + a16z with Vijay Pande

Recently, a16z Bio + Health general partner Julie Yoo spoke with Nikita Singareddy, cofounder of Fortuna, and Florian Otto, cofounder of Cedar. They talked about why healthcare affordability is reaching a breaking point, how AI voice agents are transforming patient financial expe ... Show More

Out-of-Pocket is a healthcare education company founded by Nikhil Krishnan that helps people understand how healthcare works and how to navigate it in practice. In this episode, a16z investing partner Jay Rughani and Nikhil discuss why health insurance is losing its role as the d ... Show More

Cofounders Jeremy Wohlwend and Gabriele Corso join the a16z podcast to discuss the launch of Boltz, a public benefit company building AI infrastructure for molecular biology. The conversation explains how breakthroughs following AlphaFold moved the field beyond protein structure ... Show More

Jon Krohn talks to Varun Godbole about AI prompt engineering, generative wisdom, and AI generalists in this episode all about the interrelationships between humans and AI. Additional materials: www.superdatascience.com/869 This episode is brought to you by the Dell AI Factory w ... Show More

<p>In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. Vijay Pande, a general partner at Andreessen Horowitz (A16Z) where he leads investments in health care and life sciences. The conversation explores Pande’s journey from academia to venture ca ... Show More

Trends in open-source AI: Join Jon Krohn and a panel of data science icons as they discuss the most exciting and concerning developments in open-source AI. Hear insights from Drew Conway, Jared Lander, Emily Zabor, and JD Long on the transformative potential of AI and its future ... Show More

On the first episode of the OpenAI Podcast, Sam Altman joins host Andrew Mayne to talk about the future of AI: from GPT-5 and AGI to Project Stargate, new research workflows, and AI-powered parenting. 00:00Welcome to the OpenAI Podcast01:00ChatGPT & parenthood04:10AGI, superintel ... Show More

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ... Show More

2025 has thus far been a year of great leaps and advances in AI technology. And Sarah and Elad have spoken with some of the most enterprising founders and scientific minds in the field of AI today. So we’re revisiting a few of our favorite conversations on No Priors so far in 202 ... Show More

Listen as two leading researchers at the cutting edge of computational biology explore breakthrough GPU accelerations that are changing how we understand life's molecular machinery. Chris Dallago, Research Lead at NVIDIA and Visiting Professor at Duke University, and Martin Stein ... Show More